a good radio transcript about the conference, page-15

have,nt we already been told management intends to sellon the technology before it goes to market.They want to find a big pharmo to do the really hard bits (for us) after all is,nt that what they do every day of the year.
So it would seem the object now is to make the case for the best price for the selloff.A major conference in our own backyard about malaria is very timely for this end.It would be nice to be able to sprook the recent results at this conference......I dont know if that is possible.
Whatever way you look at it a market cap of around $20m repesents at least a 10 bagger($200m market cap)as a realistic price for a proven malaria treatment ready for market.